[Severe eosinophilia after administering low subcutaneous doses of interleukin-2].
Martínez
E
E
Arias
F
F
Domínguez
M A
MA
Mateos
M C
MC
D000208:Acute Disease; D004802:Eosinophilia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged
D007376:Interleukin-2
Eosinofilia intensa después de administrar dosis subcutáneas bajas de interleucina-2.